Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-19 4:05 pm Purchase | 13G | ISORAY INC ISR | COMMODORE CAPITAL LP | 38,906,673 6.6% | 38,906,673 (New Position) | View |
| 2024-03-21 4:05 pm Purchase | 13G | MIND MEDICINE MINDMED INC MNMD | COMMODORE CAPITAL LP | 5,833,333 8.3% | 5,833,333 (New Position) | View |
| 2024-02-14 4:10 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | COMMODORE CAPITAL LP | 5,450,000 12.3% | 448,217 (+8.96%) | View |
| 2024-02-14 4:05 pm Sale | 13G | IMMUNIC INC IMUX | COMMODORE CAPITAL LP | 0 0% | -2,873,563 (Position Closed) | View |
| 2024-02-14 4:05 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | COMMODORE CAPITAL LP | 10,000,000 9.9% | 3,841,859 (+62.39%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 6,172,086 7.1% | 1,246,086 (+25.30%) | View |
| 2024-02-14 4:05 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 0 0% | -5,738,500 (Position Closed) | View |
| 2024-02-14 4:05 pm Unchanged | 13G | AMBRX BIOPHARMA INC AMAM | COMMODORE CAPITAL LP | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 4:05 pm Purchase | 13G | CABALETTA BIO INC CABA | COMMODORE CAPITAL LP | 1,900,000 4.4% | 441,633 (+30.28%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | CELCUITY INC CELC | COMMODORE CAPITAL LP | 2,492,886 9.9% | 235,474 (+10.43%) | View |
| 2024-02-14 4:05 pm Sale | 13G | SOLENO THERAPEUTICS INC PA SLNO | COMMODORE CAPITAL LP | 700,000 2.3% | -185,741 (-20.97%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | COMMODORE CAPITAL LP | 1,934,084 5.4% | 100,000 (+5.45%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | COMMODORE CAPITAL LP | 2,901,816 7% | 819,693 (+39.37%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | MERUS N V COM MRUS | COMMODORE CAPITAL LP | 4,747,373 8.2% | 2,014,806 (+73.73%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | SAB BIOTHERAPEUTICS INC NE SABS | COMMODORE CAPITAL LP | 1,831,746 3.5% | 1,831,746 (New Position) | View |
| 2024-02-14 4:05 pm Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | COMMODORE CAPITAL LP | 1,924,074 3.7% | -96,092 (-4.76%) | View |
| 2024-02-14 4:05 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | COMMODORE CAPITAL LP | 5,001,783 11.3% | 2,658,926 (+113.49%) | View |
| 2024-01-19 4:05 pm Purchase | 13G | ADICET BIO INC ACET | COMMODORE CAPITAL LP | 4,250,000 9.8% | 4,250,000 (New Position) | View |
| 2023-12-22 4:05 pm Purchase | 13G | C4 THERAPEUTICS INC CCCC | COMMODORE CAPITAL LP | 3,800,000 7.7% | 3,800,000 (New Position) | View |
| 2023-12-01 4:15 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | COMMODORE CAPITAL LP | 1,834,084 6.1% | 1,834,084 (New Position) | View |